Biosynthesis of Novel Statins by Combining Heterologous Genes from Xylaria and Aspergillus
Hiroya Itoh1,2, Makoto Matsui1,2, Yuki Miyamura2
1Biotechnology Laboratories , Astellas Pharma Inc. , Tokodai 5-2-3 , Tsukuba, Ibaraki 300-2635 , Japan.
Abstract:
For many secondary metabolites, heterologous synthesis is the definitive step to determine their required biosynthetic genes. Using a multivector expression system in Saccharomyces cerevisiae, we reconstituted not only two natural statins from two fungal species, i.e., lovastatin from Aspergillus terreus and FR901512 from Xylaria grammica, but also new statin structures by mixing their genes. Combinatorial gene exchange experiments revealed the functional promiscuity of two polyketide synthases in A. terreus, lovB, and lovF; they could synthesize FR901512 with Xylaria genes. Key structure determinants of statins are essential accessory genes that are irreplaceable across species.
Related Concept Videos
Biosynthesis in Bacteria
Biosynthesis of Polysaccharides
Biosynthesis of Lipids
Biosynthesis of Nucleic Acids
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Insulin: Biosynthesis, Chemistry, and Preparation
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment...


